Liom

Liom is an early-stage, privately-held biotechnology company based in Lausanne, Switzerland, focused on revolutionizing metabolic health monitoring. The company is developing a first-of-its-kind wearable device that uses proprietary technology to measure glucose levels continuously and non-invasively, integrating this data with a comprehensive suite of other health metrics. Led by a seasoned team with expertise in entrepreneurship, MedTech R&D, and biomedical informatics, Liom aims to shift glucose monitoring from a reactive diabetic management tool to a proactive wellness platform for a broader consumer and pre-diabetic population. The company is currently in the pre-revenue, pre-clinical/development stage, building its technology and preparing for clinical validation.

Proprietary non-invasive sensor technology (likely optical/bioimpedance-based) combined with AI/ML algorithms for continuous glucose monitoring and multi-parameter health analytics, integrated into a wearable device.

Liom competes directly with invasive CGM leaders (Dexcom, Abbott) and indirectly with fitness wearables (Apple, Fitbit, Whoop). It also faces potential competition from other non-invasive glucose monitoring startups (e.g., Know Labs, SugarBEAT) and tech giants (Apple, Google) with vast R&D resources in sensor technology.